4-Hydroxynonenal suppresses IL-10 production during infection

preprint OA: closed
📄 Open PDF Full text JSON View at publisher

Abstract

Sepsis is a syndrome of life-threatening multiple organ failure induced by infection and hallmarked by the increased production of inflammatory cytokines and reactive oxygen species (ROS). The oxidation of lipids by ROS produces 4-hydroxynonenal (4-HNE), a highly reactive aldehyde that forms adducts with proteins and thereby impacts immune signaling. In this study, using blood samples from patients with sepsis at the emergency department, collected by the Acutelines data- and biobank, we show that 4-HNE selectively suppresses the production of the anti-inflammatory cytokine interleukin (IL)-10, while pro-inflammatory IL-6 and tumor necrosis factor (TNF)-α are unaffected. Mechanistically, 4-HNE causes a pronounced transcriptional reorganization, leading to metabolic reprogramming and activation of HIF-1α signaling. In turn, this suppresses IL-10 production through inhibition of nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) signaling, whereas IL-6 and TNF-α are unaffected due to increased activation of p38 mitogen-activated protein kinase (MAPK) signaling. This suppression likely occurs in sepsis, because, whereas overall 4-HNE protein adduct levels are increased in blood samples of sepsis patients, they are decreased in monocytes and T cells and negatively correlate with IL-10 levels. Thus, our data show that 4-HNE selectively suppresses IL-10 production in sepsis. This is likely relevant to the clinical outcome of sepsis patients because IL-10 levels correlate with mortality. Graphical abstract
Full text 1,645 characters · extracted from oa-doi-fallback · click to expand
Abstract Sepsis is a syndrome of life-threatening multiple organ failure induced by infection and hallmarked by the increased production of inflammatory cytokines and reactive oxygen species (ROS). The oxidation of lipids by ROS produces 4-hydroxynonenal (4-HNE), a highly reactive aldehyde that forms adducts with proteins and thereby impacts immune signaling. In this study, using blood samples from patients with sepsis at the emergency department, collected by the Acutelines data- and biobank, we show that 4-HNE selectively suppresses the production of the anti-inflammatory cytokine interleukin (IL)-10, while pro-inflammatory IL-6 and tumor necrosis factor (TNF)-α are unaffected. Mechanistically, 4-HNE causes a pronounced transcriptional reorganization, leading to metabolic reprogramming and activation of HIF-1α signaling. In turn, this suppresses IL-10 production through inhibition of nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) signaling, whereas IL-6 and TNF-α are unaffected due to increased activation of p38 mitogen-activated protein kinase (MAPK) signaling. This suppression likely occurs in sepsis, because, whereas overall 4-HNE protein adduct levels are increased in blood samples of sepsis patients, they are decreased in monocytes and T cells and negatively correlate with IL-10 levels. Thus, our data show that 4-HNE selectively suppresses IL-10 production in sepsis. This is likely relevant to the clinical outcome of sepsis patients because IL-10 levels correlate with mortality. Graphical abstract Competing Interest Statement The authors filed a patent related to 4-HNE-based diagnostics.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00